Trial Profile
FACTIVE Outpatients Respiratory Infection Community Experience
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Jan 2007
Price :
$35
*
At a glance
- Drugs Gemifloxacin (Primary) ; Amoxicillin/clavulanic acid; Clarithromycin
- Indications Acute exacerbations of chronic bronchitis; Bacterial infections; Community-acquired pneumonia
- Focus Therapeutic Use
- Acronyms FORCE
- Sponsors Oscient Pharmaceuticals
- 31 Jan 2007 New trial record.